The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Neurodegenerative Diseases Market Insights, Forecast to 2025

Global Neurodegenerative Diseases Market Insights, Forecast to 2025

Publishing Date : Jan, 2019

License Type :
 

Report Code : 1367331

No of Pages : 127

Synopsis
Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characterized by neuronal death within the brain and/or central nervous system (CNS), leading to progressive decline in functional neurological capacities. It has a devastating effect on quality of life and independence, often requiring full-time care during the later disease stages.

Summary
Global Neurodegenerative Diseases Market value is expected to grow from US$ XX Million in 2018 to US$ YY Million by 2025, at a Compound Annual Growth Rate (CAGR) of ZZ% during 2019-2025 as per ‘Global Neurodegenerative Diseases Market Insights, Forecast to 2025’ research report. The objectives of this report are to define and to segment the Neurodegenerative Diseases market based on product types, top companies, key regions and by end users.

This report studies the consumption pattern of Neurodegenerative Diseases market in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. In addition, this report also covers global Neurodegenerative Diseases market status, competitive landscape, market share, growth rate, future trends, market drivers, opportunities, challenges, sales channels and distributors.

Key companies covered in this report are:
(This report focuses on the key Neurodegenerative Diseases market companies in the terms of company basic details, business overview, sales, revenue, gross margin, products, recent development, etc)

  • Novartis
  • Merck Serono
  • Teva Pharmaceutical
  • Ucb
  • Pfizer
  • Biogen Idec
  • Bayer Schering Pharma Ag
  • Boehringer Ingelheim
  • Addex Pharmaceutical
  • Amarin
  • Astrazeneca
  • Asubio Pharmaceutical
  • Bial
  • Alector
  • Yumanity Therapeutics
  • Eisai
  • H.Lundbeck A/S
  • Jiangsu Hansoh Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • Chongqing Zein Pharmaceutical

Neurodegenerative Diseases Market is categorized on the basis of following product types:
(Each product type is covered in the terms of growth rate, sales, revenue, price, regional analysis, sales & revenue forecast, etc.)

  • NMDA
  • SSRIs
  • Dopamine Inhibitors

Neurodegenerative Diseases Market is studied for the following applications (End Users Segment):
(Each application is covered in the terms of growth rate, segmentation by end users, regional analysis, estimated forecast, etc)

  • Parkinson’s disease
  • Huntington disease
  • Amyotrophic Lateral Sclerosis
  • Alzheimer’s disease

Market segment by Regions/Countries, this report covers:
• North America (United States, Canada, Mexico)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam)
• Europe (Germany, France, UK, Italy, Russia)
• Central & South America (Brazil, Rest of Central & South America)
• Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa)

Objectives of Global Neurodegenerative Diseases Market report are:
• To understand the global Neurodegenerative Diseases market size (value & volume) by companies, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025
• To get the in-depth knowledge of Neurodegenerative Diseases market by identifying its various segments and sub-segments
• To obtain detailed information about the key factors influencing the growth of the market and study of various parameters effective the market like growth potential, opportunities, drivers, industry-specific challenges and risks
• Focuses on the key global Neurodegenerative Diseases market companies, comparing their sales volume, value, market share, market competitive landscape and recent developments
• To estimate the sales volume and value of Neurodegenerative Diseases market / submarkets, with respect to key regions
• To identify competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

Topics covered in this report are:
1 Study Coverage (Overview, market segmentation by product types, end users)
2 Executive Summary (Market size, revenue and sales by regions)
3 Breakdown Data by Manufacturers (Sales, market share, revenue, price, distribution, product types)
4 Breakdown Data by Product (Sales, revenue, price)
5 Breakdown Data by End User (Segmentation by application)
6 North America (Sales, revenue segmentation by countries, segmentation by types & application)
7 Europe (Sales, revenue segmentation by countries, segmentation by types & application)
8 Asia Pacific (Sales, revenue segmentation by countries, segmentation by types & application)
9 Central & South America (Sales, revenue segmentation by countries, segmentation by types & application)
10 Middle East and Africa (Sales, revenue segmentation by countries, segmentation by types & application)
11 Company Profiles (Basic company details, business overview, sales, revenue, gross margin, developments)
12 Future Forecast (Forecast by regions, product types, end users)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis (Market effective factors, macroscopic indicators)
14 Value Chain and Sales Channels Analysis (Customers, distributors)
15 Research Findings and Conclusion (Finding of the research)

Index

Table of Contents

1 Study Coverage
1.1 Neurodegenerative Diseases Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Neurodegenerative Diseases Market Size Growth Rate by Product
1.4.2 NMDA
1.4.3 SSRIs
1.4.4 Dopamine Inhibitors
1.5 Market by End User
1.5.1 Global Neurodegenerative Diseases Market Size Growth Rate by End User
1.5.2 Parkinson’s disease
1.5.3 Huntington disease
1.5.4 Amyotrophic Lateral Sclerosis
1.5.5 Alzheimer’s disease
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Neurodegenerative Diseases Market Size
2.1.1 Global Neurodegenerative Diseases Revenue 2014-2025
2.1.2 Global Neurodegenerative Diseases Sales 2014-2025
2.2 Neurodegenerative Diseases Growth Rate by Regions
2.2.1 Global Neurodegenerative Diseases Sales by Regions
2.2.2 Global Neurodegenerative Diseases Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Neurodegenerative Diseases Sales by Manufacturers
3.1.1 Neurodegenerative Diseases Sales by Manufacturers
3.1.2 Neurodegenerative Diseases Sales Market Share by Manufacturers
3.1.3 Global Neurodegenerative Diseases Market Concentration Ratio (CR5 and HHI)
3.2 Neurodegenerative Diseases Revenue by Manufacturers
3.2.1 Neurodegenerative Diseases Revenue by Manufacturers (2014-2019)
3.2.2 Neurodegenerative Diseases Revenue Share by Manufacturers (2014-2019)
3.3 Neurodegenerative Diseases Price by Manufacturers
3.4 Neurodegenerative Diseases Manufacturing Base Distribution, Product Types
3.4.1 Neurodegenerative Diseases Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neurodegenerative Diseases Product Type
3.4.3 Date of International Manufacturers Enter into Neurodegenerative Diseases Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Neurodegenerative Diseases Sales by Product
4.2 Global Neurodegenerative Diseases Revenue by Product
4.3 Neurodegenerative Diseases Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Neurodegenerative Diseases Breakdown Data by End User

6 North America
6.1 North America Neurodegenerative Diseases by Countries
6.1.1 North America Neurodegenerative Diseases Sales by Countries
6.1.2 North America Neurodegenerative Diseases Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Neurodegenerative Diseases by Product
6.3 North America Neurodegenerative Diseases by End User

7 Europe
7.1 Europe Neurodegenerative Diseases by Countries
7.1.1 Europe Neurodegenerative Diseases Sales by Countries
7.1.2 Europe Neurodegenerative Diseases Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neurodegenerative Diseases by Product
7.3 Europe Neurodegenerative Diseases by End User

8 Asia Pacific
8.1 Asia Pacific Neurodegenerative Diseases by Countries
8.1.1 Asia Pacific Neurodegenerative Diseases Sales by Countries
8.1.2 Asia Pacific Neurodegenerative Diseases Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Neurodegenerative Diseases by Product
8.3 Asia Pacific Neurodegenerative Diseases by End User

9 Central & South America
9.1 Central & South America Neurodegenerative Diseases by Countries
9.1.1 Central & South America Neurodegenerative Diseases Sales by Countries
9.1.2 Central & South America Neurodegenerative Diseases Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Neurodegenerative Diseases by Product
9.3 Central & South America Neurodegenerative Diseases by End User

10 Middle East and Africa
10.1 Middle East and Africa Neurodegenerative Diseases by Countries
10.1.1 Middle East and Africa Neurodegenerative Diseases Sales by Countries
10.1.2 Middle East and Africa Neurodegenerative Diseases Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Neurodegenerative Diseases by Product
10.3 Middle East and Africa Neurodegenerative Diseases by End User

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis Neurodegenerative Diseases Products Offered
11.1.5 Novartis Recent Development
11.2 Merck Serono
11.2.1 Merck Serono Company Details
11.2.2 Company Business Overview
11.2.3 Merck Serono Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Serono Neurodegenerative Diseases Products Offered
11.2.5 Merck Serono Recent Development
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Details
11.3.2 Company Business Overview
11.3.Teva Pharmaceutical Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Teva Pharmaceutical Neurodegenerative Diseases Products Offered
11.3.5 Teva Pharmaceutical Recent Development
11.4 UCB
11.4.1 UCB Company Details
11.4.2 Company Business Overview
11.4.3 UCB Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.4.4 UCB Neurodegenerative Diseases Products Offered
11.4.5 UCB Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer Neurodegenerative Diseases Products Offered
11.5.5 Pfizer Recent Development
11.6 Biogen Idec
11.6.1 Biogen Idec Company Details
11.6.2 Company Business Overview
11.6.3 Biogen Idec Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Biogen Idec Neurodegenerative Diseases Products Offered
11.6.5 Biogen Idec Recent Development
11.7 Bayer Schering Pharma AG
11.7.1 Bayer Schering Pharma AG Company Details
11.7.2 Company Business Overview
11.7.3 Bayer Schering Pharma AG Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Bayer Schering Pharma AG Neurodegenerative Diseases Products Offered
11.7.5 Bayer Schering Pharma AG Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Company Business Overview
11.8.3 Boehringer Ingelheim Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Boehringer Ingelheim Neurodegenerative Diseases Products Offered
11.8.5 Boehringer Ingelheim Recent Development
11.9 Addex Pharmaceutical
11.9.1 Addex Pharmaceutical Company Details
11.9.2 Company Business Overview
11.9.3 Addex Pharmaceutical Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Addex Pharmaceutical Neurodegenerative Diseases Products Offered
11.9.5 Addex Pharmaceutical Recent Development
11.10 Amarin
11.10.1 Amarin Company Details
11.10.2 Company Business Overview
11.10.3 Amarin Neurodegenerative Diseases Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Amarin Neurodegenerative Diseases Products Offered
11.10.5 Amarin Recent Development
11.11 AstraZeneca
11.12 Asubio Pharmaceutical
11.13 Bial
11.14 Alector
11.15 Yumanity Therapeutics
11.16 Eisai
11.17 H.Lundbeck A/S
11.18 Jiangsu Hansoh Pharmaceutical
11.19 Yangtze River Pharmaceutical Group
11.20 Chongqing Zein Pharmaceutical

12 Future Forecast
12.1 Neurodegenerative Diseases Market Forecast by Regions
12.1.1 Global Neurodegenerative Diseases Sales Forecast by Regions 2019-2025
12.1.2 Global Neurodegenerative Diseases Revenue Forecast by Regions 2019-2025
12.2 Neurodegenerative Diseases Market Forecast by Product
12.2.1 Global Neurodegenerative Diseases Sales Forecast by Product 2019-2025
12.2.2 Global Neurodegenerative Diseases Revenue Forecast by Product 2019-2025
12.3 Neurodegenerative Diseases Market Forecast by End User
12.4 North America Neurodegenerative Diseases Forecast
12.5 Europe Neurodegenerative Diseases Forecast
12.6 Asia Pacific Neurodegenerative Diseases Forecast
12.7 Central & South America Neurodegenerative Diseases Forecast
12.8 Middle East and Africa Neurodegenerative Diseases Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neurodegenerative Diseases Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables

List of Tables and Figures

Figure Neurodegenerative Diseases Product Picture
Table Neurodegenerative Diseases Market Segments
Table Key Manufacturers Neurodegenerative Diseases Covered
Table Global Neurodegenerative Diseases Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Neurodegenerative Diseases Sales Market Share by Product 2014-2025
Figure NMDA Product Picture
Table Major Manufacturers of NMDA
Figure SSRIs Product Picture
Table Major Manufacturers of SSRIs
Figure Dopamine Inhibitors Product Picture
Table Major Manufacturers of Dopamine Inhibitors
Table Global Neurodegenerative Diseases Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Parkinson’s disease
Figure Huntington disease
Figure Amyotrophic Lateral Sclerosis
Figure Alzheimer’s disease
Figure Neurodegenerative Diseases Report Years Considered
Figure Global Neurodegenerative Diseases Market Size 2014-2025 (Million US$)
Figure Global Neurodegenerative Diseases Sales 2014-2025 (K Units)
Table Global Neurodegenerative Diseases Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Neurodegenerative Diseases Sales by Regions 2014-2019 (K Units)
Table Global Neurodegenerative Diseases Sales Market Share by Regions 2014-2019
Figure Global Neurodegenerative Diseases Sales Market Share by Regions 2014-2019
Figure 2018 Global Neurodegenerative Diseases Sales Market Share by Regions
Table Global Neurodegenerative Diseases Revenue by Regions 2014-2019 (Million US$)
Table Global Neurodegenerative Diseases Revenue Market Share by Regions 2014-2019
Figure Global Neurodegenerative Diseases Revenue Market Share by Regions 2014-2019
Figure 2018 Global Neurodegenerative Diseases Revenue Market Share by Regions
Table Global Neurodegenerative Diseases Sales by Manufacturers (2014-2019) (K Units)
Table Global Neurodegenerative Diseases Sales Share by Manufacturers (2014-2019)
Figure Global Neurodegenerative Diseases Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Neurodegenerative Diseases Revenue by Manufacturers (2014-2019) (Million USD)
Table Neurodegenerative Diseases Revenue Share by Manufacturers (2014-2019)
Figure Neurodegenerative Diseases Value Share by Manufacturers in 2018
Table Key Manufacturers Neurodegenerative Diseases Price (2014-2019) (USD/Unit)
Table Neurodegenerative Diseases Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Neurodegenerative Diseases Product Type
Table Date of International Manufacturers Enter into Neurodegenerative Diseases Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table Global Neurodegenerative Diseases Sales Share by Product (2014-2019)
Figure Global Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure Global Neurodegenerative Diseases Sales Market Share by Product in 2018
Table Global Neurodegenerative Diseases Revenue by Product (2014-2019) (Million US$)
Table Global Neurodegenerative Diseases Revenue Share by Product (2014-2019)
Figure Global Neurodegenerative Diseases Revenue Market Share by Product (2014-2019)
Figure Global Neurodegenerative Diseases Revenue Market Share by Product in 2018
Table Neurodegenerative Diseases Price by Product 2014-2019 (USD/Unit)
Table Global Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table Global Neurodegenerative Diseases Sales Share by End User (2014-2019)
Figure Global Sales Neurodegenerative Diseases Market Share by End User (2014-2019)
Figure Global Sales Neurodegenerative Diseases Market Share by End User in 2018
Figure North America Neurodegenerative Diseases Sales Growth Rate 2014-2019 (K Units)
Figure North America Neurodegenerative Diseases Revenue Growth Rate 2014-2019 (Million US$)
Table North America Neurodegenerative Diseases Sales by Countries (2014-2019) (K Units)
Table North America Neurodegenerative Diseases Sales Market Share by Countries (2014-2019)
Figure 2018 North America Neurodegenerative Diseases Sales Market Share by Countries
Table North America Neurodegenerative Diseases Revenue by Countries (2014-2019) (Million US$)
Table North America Neurodegenerative Diseases Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Neurodegenerative Diseases Revenue Market Share by Countries
Figure United States Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure United States Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Canada Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Table North America Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table North America Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure 2018 North America Neurodegenerative Diseases Market Share by Product
Table North America Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table North America Neurodegenerative Diseases Sales Market Share by End User (2014-2019)
Figure 2018 North America Neurodegenerative Diseases Market Share by End User
Figure Europe Neurodegenerative Diseases Sales Growth Rate 2014-2019 (K Units)
Figure Europe Neurodegenerative Diseases Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Neurodegenerative Diseases Sales by Countries (2014-2019) (K Units)
Table Europe Neurodegenerative Diseases Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Neurodegenerative Diseases Sales Market Share by Countries
Table Europe Neurodegenerative Diseases Revenue by Countries (2014-2019) (Million US$)
Table Europe Neurodegenerative Diseases Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Neurodegenerative Diseases Revenue Market Share by Countries
Figure Germany Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Germany Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure France Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure France Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure UK Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Italy Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Russia Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table Europe Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure 2018 Europe Neurodegenerative Diseases Market Share by Product
Table Europe Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table Europe Neurodegenerative Diseases Sales Market Share by End User (2014-2019)
Figure 2018 Europe Neurodegenerative Diseases Market Share by End User
Figure Asia Pacific Neurodegenerative Diseases Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Neurodegenerative Diseases Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Neurodegenerative Diseases Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Neurodegenerative Diseases Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Neurodegenerative Diseases Sales Market Share by Countries
Table Asia Pacific Neurodegenerative Diseases Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Neurodegenerative Diseases Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Neurodegenerative Diseases Revenue Market Share by Countries
Figure China Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure China Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Japan Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Korea Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure India Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure India Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Australia Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table Asia Pacific Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Neurodegenerative Diseases Market Share by Product
Table Asia Pacific Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table Asia Pacific Neurodegenerative Diseases Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Neurodegenerative Diseases Market Share by End User
Figure Central & South America Neurodegenerative Diseases Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Neurodegenerative Diseases Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Neurodegenerative Diseases Sales by Countries (2014-2019) (K Units)
Table Central & South America Neurodegenerative Diseases Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Neurodegenerative Diseases Sales Market Share by Countries
Table Central & South America Neurodegenerative Diseases Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Neurodegenerative Diseases Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Neurodegenerative Diseases Revenue Market Share by Countries
Figure Brazil Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table Central & South America Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Neurodegenerative Diseases Market Share by Product
Table Central & South America Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table Central & South America Neurodegenerative Diseases Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Neurodegenerative Diseases Market Share by End User
Figure Middle East and Africa Neurodegenerative Diseases Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Neurodegenerative Diseases Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Neurodegenerative Diseases Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries
Table Middle East and Africa Neurodegenerative Diseases Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries
Figure GCC Countries Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Neurodegenerative Diseases Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Neurodegenerative Diseases Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Neurodegenerative Diseases Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Neurodegenerative Diseases Market Share by Product
Table Middle East and Africa Neurodegenerative Diseases Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Neurodegenerative Diseases Market Share by End User
Table Novartis Company Details
Table Novartis Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development

Table Merck Serono Company Details
Table Merck Serono Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Serono Recent Development

Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Recent Development

Table UCB Company Details
Table UCB Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table UCB Recent Development

Table Pfizer Company Details
Table Pfizer Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Biogen Idec Company Details
Table Biogen Idec Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Idec Recent Development

Table Bayer Schering Pharma AG Company Details
Table Bayer Schering Pharma AG Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Schering Pharma AG Recent Development

Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development

Table Addex Pharmaceutical Company Details
Table Addex Pharmaceutical Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Addex Pharmaceutical Recent Development

Table Amarin Company Details
Table Amarin Neurodegenerative Diseases Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Amarin Recent Development

Table AstraZeneca Company Details
Table Asubio Pharmaceutical Company Details
Table Bial Company Details
Table Alector Company Details
Table Yumanity Therapeutics Company Details
Table Eisai Company Details
Table H.Lundbeck A/S Company Details
Table Jiangsu Hansoh Pharmaceutical Company Details
Table Yangtze River Pharmaceutical Group Company Details
Table Chongqing Zein Pharmaceutical Company Details
Table Global Neurodegenerative Diseases Sales Forecast by Regions 2019-2025 (K Units)
Table Global Neurodegenerative Diseases Sales Market Share Forecast by Regions 2019-2025
Table Global Neurodegenerative Diseases Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Neurodegenerative Diseases Revenue Market Share Forecast by Regions 2019-2025
Table Global Neurodegenerative Diseases Sales Forecast by Product 2019-2025 (K Units)
Table Global Neurodegenerative Diseases Sales Market Share Forecast by Product 2019-2025
Table Global Neurodegenerative Diseases Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Neurodegenerative Diseases Revenue Market Share Forecast by Product 2019-2025
Table Global Neurodegenerative Diseases Sales Forecast by End User 2019-2025 (K Units)
Table Global Neurodegenerative Diseases Sales Market Share Forecast by End User 2019-2025
Figure North America Neurodegenerative Diseases Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Neurodegenerative Diseases Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Neurodegenerative Diseases Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Neurodegenerative Diseases Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Neurodegenerative Diseases Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Neurodegenerative Diseases Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Neurodegenerative Diseases Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Neurodegenerative Diseases Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Neurodegenerative Diseases Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Neurodegenerative Diseases Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Neurodegenerative Diseases Value Chain
Table Neurodegenerative Diseases Customers List
Table Neurodegenerative Diseases Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Published By : QY Research

Why ‘The Market Reports’